Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseasesEléonore Beurel(University of Miami), Steven F. Grieco(University of Miami), Richard S. Jope(University of Miami)Pharmacology & TherapeuticsNovember 29, 201410.1016/j.pharmthera.2014.11.016Cited by 1,742Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersSteroid receptor coactivator-1 is a histone acetyltransferaseThomas E. Spencer, Guido Jenster, Mark Burcin et al.|Nature|1997|1.3kGSK-3α regulates production of Alzheimer's disease amyloid-β peptidesChristopher J. Phiel, Clare Wilson, Virginia M.‐Y. Lee et al.|Nature|2003|1.2kModulation of the glycogen synthase kinase‐3 family by tyrosine phosphorylation.K. Hughes, Eleni Nikolakaki, Simon Plyte et al.|The EMBO Journal|1993|627Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes.Nigel T. Goode, K. Hughes, James R. Woodgett et al.|Journal of Biological Chemistry|1992|394Structure of GSK3beta reveals a primed phosphorylation mechanism.Ernst ter Haar, Joyce T. Coll, Douglas A. Austen et al.|Nature Structural Biology|2001|386